ArticleCancers2019

Inhibition of TFF3 Enhances Sensitivity-and Overcomes Acquired Resistance-to Doxorubicin in Estrogen Receptor-Positive Mammary Carcinoma.

Han Ming Poh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.